Correlation of expression of Topoisomerase-I with perfusion chemotherapy by HCPT/cDDP and its relationship with prognosis in malignant effusions

Liu Bao-rui
2012-01-01
Journal of Modern Oncology
Abstract:Objective:To study the effect of pour into cDDP(cis-Diaminedichloroplatinum) or HCPT(Hydroxycamptothecin) and the relation with the expression of topoisomerase-I in malignant effusions and its relationship with prognosis.Methods: We modified the current cell block preparation method for effusion samples by adding a cylinder to obtain more cell pellets.Immunocytochemistry was used for topoisomerase-I with the tumor cells in the malignant serous cavity effusions.The over all survival(OS) was analyzed by Kaplan-Meier method,and the relationship with prognosis was analyzed by multi-variate of Cox regression.Results: We collected 35 samples of cavity effusions,including 17 with low expression and 18 high expression.There were no significant correlation to the expression of topoisomerase-I with the serum CEA(P=0.368) and LDH(P=0.754).The median survival time of the low expression group was 13 months,and the high expression group was 35 months(P=0.057).They were not independent prognostic factors of the gender,age,pleural fluid or peritoneal fluid,the serum CEA and LDH which were analyzed by multi-variate of Cox regression.Conclusion: TOPO-I protein examination for the advanced tumor patients `with malignant serous cavity effusions,could guide the individualized treatment,which may reduces the side effect,increases the curative effect.It's need further study to confirm the result of our research,because of the limited amount samples.
What problem does this paper attempt to address?